Caudate lobe-sparing subtotal hepatectomy as treatment for extensive intrahepatic arterioportal fistula  被引量:2

在线阅读下载全文

作  者:Rui Tang Guang-Dong Wu Ang Li Li-Han Yu Xuan Tong Jun Yan Qian Lu 

机构地区:[1]Hepatopancreatobiliary Center,Beijing Tsinghua Changgung Hospital,School of Clinical Medicine,Institute for Precision Medicine,Tsinghua University,Beijing 102218,China

出  处:《Hepatobiliary & Pancreatic Diseases International》2023年第4期409-411,共3页国际肝胆胰疾病杂志(英文版)

基  金:supported by a grant from the National Natural Science Foundation of China(81930119).

摘  要:Intrahepatic arterioportal fistulas(APFs)are abnormal hepatic artery and portal vein(PV)communications that develop as a result of congenital malformation,trauma,ruptured hepatic aneurysm,cirrhosis,tumor-related changes,biopsy,chemotherapy or iatrogenic causes[1,2].The most common symptoms are gastrointestinal bleeding and ascites secondary to portal hypertension;other symptoms include abdominal pain,pyrexia,edema,back pain and jaundice[3].The main goal of therapy is to decrease the portal pressure with variceal bleeding being the absolute indi-cation for surgical management.Transarterial embolization(TAE)should be the first choice to treat APFs,while resection,portocaval shunt and even transplantation may cure APFs in the case of TAE failure[4].In previous reports,caudate lobe-sparing subtotal hep-atectomy(CLSSH)has been applied for the treatment of primary hepatolithiasis and hepatocellular carcinoma[5,6].As far as we know,this is the first report describing CLSSH as treatment for an extensive intrahepatic APF,which involved segments 2 to 8,with corresponding hypertrophy of the caudate lobe.

关 键 词:TREATMENT chemotherapy ARTERIAL 

分 类 号:R657.3[医药卫生—外科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象